• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Addition Technology forms foundation for keratoconus sufferers


Addition Technology Inc. has established the Foundation for Keratoconus Care to provide financial support to patients with keratoconus who may not have the means to acquire micro-thin prescription inserts (Intacs).

The non-profit foundation will also provide a patient-assistance program to counsel patients on clinical options, including the selection of primary and surgical eye-care practices, as well as support clinical research for the disease through grants.

Michael R. Southard has been appointed executive director of the foundation. As an eye-care executive with more than 30 years’ experience, Southard most recently worked for Wesley Jessen and CIBA Vision.

Funding for the foundation will be provided by public and private sources. Addition Technology will contribute a percentage of sales from the micro-thin prescription inserts to the foundation. For more information, visit www.keratoconuscare.org.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.